Aim and Scope

The Emerging Molecular Sciences is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research in molecular and biochemical sciences. As a non-profit publication, it aims to advance molecular understanding of biological systems by offering a platform for molecular biologists, biochemists, and structural scientists to share their findings and innovations.

This journal encompasses a wide range of subjects related to molecular sciences. Areas of interest include, but are not limited to:

Molecular Biology and Genetics: This includes gene expression, gene regulation, DNA replication and repair, RNA biology, epigenetics, and genome editing technologies such as CRISPR.

Biochemistry and Structural Biology: Topics include protein structure and function, enzyme kinetics, metabolic pathways, protein folding, cryo-electron microscopy, and X-ray crystallography.

Cell Signalling and Systems Biology: This encompasses signal transduction pathways, intracellular communication, systems-level analysis, network biology, and computational modelling of biological processes.

Genomics, Proteomics, and Metabolomics: Areas covered include next-generation sequencing, mass spectrometry-based proteomics, metabolite profiling, bioinformatics, and multi-omics integration.

Molecular Diagnostics and Biotechnology: This section covers diagnostic assay development, molecular tools, synthetic biology, biomarker discovery, and translational molecular medicine.

Conflict of Interest

All authors, reviewers, and editors are required to disclose any potential conflicts of interest related to their submission or participation in the review process. Conflicts of interest may include financial, professional, or personal relationships that could influence the outcome of the work.

Open Access Policy

The Emerging Molecular Sciences is committed to an Open Access publishing model, ensuring that all articles are freely accessible to the public. Published under a Creative Commons Attribution License (CC BY), our policy allows for unrestricted use and distribution with appropriate attribution to the authors.  Authors retain copyright of their work, and  Article Processing Charges (APCs) incurred support the journal's operations while maintaining rigorous peer review and publication standards.

Copyright and Licensing

When submitting an article, authors are required to agree to an open access Creative Commons (CC BY 4.0) license. This license allows authors to retain copyright of their work while granting users the right to download, print, reuse, share, and distribute the article, provided that proper credit is given to the authors and the original source. This ensures maximum visibility and availability of the article, allowing it to be included in scientific archives. Consistent with open access principles, the journal makes all article abstracts and full-text PDFs freely accessible to the public upon publication.

Digital archiving policy

This journal utilizes the PKP Preservation Network, Global LOCKSS Network, and Portico to establish a distributed archiving system across participating libraries. These networks enable libraries to maintain permanent archives of the journal, ensuring its long-term preservation and restoration capabilities.

Plagiarism policy

The Emerging Molecular Sciences is committed to maintaining the highest standards of integrity and academic ethics. We have a zero-tolerance policy towards plagiarism in all its forms. All submitted manuscripts are screened for plagiarism using advanced detection tools (Turnitin and iThenticate). Any form of plagiarism, including direct copying, paraphrasing without proper attribution, or self-plagiarism, is prohibited. If detected before publication, the manuscript will be rejected. If discovered after publication, the journal will retract or correct the article and notify readers of the misconduct. Authors are responsible for ensuring that their work is original, properly cited, and does not infringe on the intellectual property of others.

Publishing Ethics

When submitting studies involving human participants, authors must follow ICMJE recommendations on privacy and informed consent. Identifiable patient data such as descriptions, photos, or genetic information can only be published with written informed consent, which requires showing the patient the manuscript prior to publication. If the patient is deceased, consent must be obtained from the family or estate. Authors must secure this consent and keep records but do not need to submit them to the journal. Consent should specify that the manuscript may be published online, in print, and shared via social media.

For animal studies, authors must confirm that the animals were cared for according to institutional or national standards. All experiments should comply with relevant guidelines, and procedures must minimize harm to the animals, with anesthetics and analgesics clearly described.

Approval from an ethics committee is required for all clinical and animal studies. Researchers are encouraged to register clinical trials in public databases, such as clinicaltrials.gov, with the trial number and detailed methods included in the manuscript.

Emerging Molecular Sciences

Full title: Emerging Molecular Sciences

ISSN: 3023-347X (online)

Publisher: Emerging Publishing Society